Both EA and Na2EA treatment led to a decrease in AML cells, as observed by monitoring CD33 + but not CD45 + cells in the PB of THP-1 mice (Figures S10A and S10B, respectively). This evidence concerns the gene CD33 and acute myeloid leukemia.